Creatinine Clearance and eGFR Calculation
For this 78-year-old female weighing 59 kg with serum creatinine 152 µmol/L, the Cockcroft-Gault creatinine clearance is approximately 24 mL/min, indicating Stage 4 chronic kidney disease (severely decreased renal function), while the eGFR by CKD-EPI 2021 equation is approximately 32 mL/min/1.73 m².
Calculations
Cockcroft-Gault Creatinine Clearance
Using the Cockcroft-Gault formula 1, 2:
CrCl (mL/min) = [(140 - age) × weight] / [72 × SCr (mg/dL)] × 0.85 (if female)
Converting SCr: 152 µmol/L ÷ 88.4 = 1.72 mg/dL
CrCl = [(140 - 78) × 59] / [72 × 1.72] × 0.85 CrCl = [62 × 59] / 123.84 × 0.85 CrCl = 3,658 / 123.84 × 0.85 CrCl ≈ 24 mL/min
Estimated GFR (CKD-EPI 2021)
Using the race-free CKD-EPI 2021 equation 3, 4:
eGFR (mL/min/1.73 m²) = 142 × min(SCr/κ, 1)^α × max(SCr/κ, 1)^-1.200 × 0.9938^age × 1.012 (if female)
Where κ = 0.7 for females, α = -0.241 for females
SCr/κ = 1.72/0.7 = 2.46
Since 2.46 > 1: min = 1, max = 2.46
eGFR = 142 × 1^-0.241 × 2.46^-1.200 × 0.9938^78 × 1.012 eGFR ≈ 32 mL/min/1.73 m²
Clinical Interpretation
CKD Staging
Based on both calculations, this patient has Stage 4 CKD (severely decreased GFR: 15-29 mL/min by CrCl or 30-44 mL/min/1.73 m² by eGFR) 1. The Cockcroft-Gault value of 24 mL/min places her in Stage 4, while the CKD-EPI value of 32 mL/min/1.73 m² is at the lower end of Stage 3b.
Which Value to Use
For medication dosing decisions, use the Cockcroft-Gault creatinine clearance (24 mL/min) 2, 4. Despite recent FDA guidance favoring eGFR equations, the Cockcroft-Gault formula remains the standard for drug dosing because:
- Most drug dosing guidelines and package inserts were developed using Cockcroft-Gault 4, 5
- The formula accounts for actual body weight, which affects drug distribution 1
- It provides an unadjusted clearance value (mL/min) rather than BSA-normalized value (mL/min/1.73 m²) 1
For assessing CKD stage and prognosis, use the eGFR (32 mL/min/1.73 m²) 6, 3, 4. The race-free CKD-EPI 2021 equation is now the recommended standard for medical decision-making and CKD classification.
Important Caveats for Elderly Patients
Limitations in the Elderly
Both equations have significant limitations in elderly patients 1:
- Cockcroft-Gault tends to underestimate GFR in the elderly, particularly in the oldest patients, due to decreased muscle mass 1
- The discrepancy is most pronounced in patients >75 years old 1
- Serum creatinine alone is particularly unreliable in elderly patients because muscle mass decreases with age, leading to falsely reassuring creatinine values 1
Muscle Mass Considerations
In this 78-year-old female with low body weight (59 kg), the serum creatinine of 152 µmol/L (1.72 mg/dL) likely reflects significantly impaired renal function despite being only modestly elevated 1. A creatinine of 1.72 mg/dL in a young, muscular individual might indicate mild dysfunction, but in an elderly woman with reduced muscle mass, it indicates severe impairment.
Clinical Action Points
- Avoid nephrotoxic medications (NSAIDs, aminoglycosides, contrast agents) 1
- Adjust all renally-cleared medications using the Cockcroft-Gault value of 24 mL/min 2
- Monitor renal function closely - even small changes in creatinine represent large changes in GFR at this level 1
- Consider nephrology referral - Stage 4 CKD warrants specialist input for preparation for potential renal replacement therapy 1
- For drugs with narrow therapeutic indices or serious toxicity (chemotherapy, anticoagulants), consider measuring GFR directly using isotopic methods if treatment decisions are critically dependent on precise GFR values 6